2017.11.26 | McCormick Place, Chicago
VUNO participated in the RSNA this year for the second time, and introduced various AI-based diagnostic solutions. We had two booths there: our main booth in the North Hall and another one in Machine Learning Pavilion. Thankfully, many people from various corporates, hospitals, and schools paid us a visit. We mainly presented VUNO-Med BoneAge, which is at its last stage to be approved in Korea, as well as VUNO-Med Chest X-ray and Chest CT products which find abnormalities and locate lesions in chest X-rays/CTs. There we were reassured that our technology is relatively superior to the products of other competitors.
The results that were presented this year will be approved or will be applied to be approved in 2018, and we will focus on R&D and commercialization of more official commercial products in order to offer beneficial products to our customers. We ask for your continuous support.